GSK Consumer Healthcare slips on uninspiring Q1 results

GlaxoSmithkline Consumer Healthcare fell 1.58% to Rs 6,254 at 12:17 IST on BSE after net profit rose 2.92% to Rs 160.61 crore on 0.91% decline in total income to Rs 1118.56 crore in Q1 June 2016 over Q1 June 2015.

The result was announced during trading hours today, 5 August 2016.

Meanwhile, the S&P BSE Sensex was up 287.41 points, or 1.04%, to 28,001.78.

On BSE, so far 555 shares were traded in the counter, compared with an average daily volume of 4,899 shares in the past one quarter. The stock hit a high of Rs 6,370 and a low of Rs 6,220 so far during the day. The stock hit a record high of Rs 6,800 on 23 December 2015. The stock hit a 52-week low of Rs 5,366.50 on 2 March 2016. The stock had outperformed the market over the past one month till 4 August 2016, rising 3.79% compared with 1.60% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 8.28% as against Sensex's 10.41% rise.

 

The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.

GlaxoSmithkline Consumer Healthcare (GSK Consumer Healthcare) is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.

Powered by Capital Market - Live News